Event Brief
Novartis, Amgen, Eli Lilly target bad cholesterol for heart drugs
Filed: Apr 28, 2026 at 1:00 PM ET
Summary: Novartis, Amgen, and Eli Lilly are betting that lowering a bad cholesterol type will drive next heart drug blockbusters.
WHO: Novartis, Amgen, Eli Lilly
WHAT: Pharma development strategy targeting a bad form of cholesterol for cardiology drugs
WHEN: Apr 27, 2026 at 3:28 PM ET
WHERE: Location not specified
WHY: They believe slashing levels of a particularly bad form of cholesterol could deliver next blockbusters.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →